208.1K XNYS Volume
XNYS 31 Mar, 2025 2:27 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.32 per share. | 14 Mar 2025 | 3,000 | 11,171 (0%) | 0% | 159.3 | 477,960 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 3,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 247.06 per share. | 14 Mar 2025 | 3,000 | 8,171 (0%) | 0% | 247.1 | 741,184 | Bio-Rad A Common Stock |
| Jonathan P. DiVincenzo | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,863 | 4,863 | - | - | Non-Qualified Stock Option (right to buy) | |
| Roop K. Lakkaraju | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 3,891 | 3,891 | - | - | Non-Qualified Stock Option (right to buy) | |
| Norman Schwartz | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 11,671 | 11,671 | - | - | Non-Qualified Stock Option (right to buy) | |
| Colleen Corey | EVP, Global Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 1,946 | 1,946 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sedat Evran | EVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 2,918 | 2,918 | - | - | Non-Qualified Stock Option (right to buy) | |
| James J. Barry | EVP, President, LSG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 2,918 | 2,918 | - | - | Non-Qualified Stock Option (right to buy) | |
| Courtney Camp Enloe | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 1,946 | 1,946 | - | - | Non-Qualified Stock Option (right to buy) | |
| Eva Anette Engelhardt | EVP, President, CDG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 2,918 | 2,918 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jonathan P. DiVincenzo | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 7,478 | 7,478 | - | - | Restricted Stock Units | |
| Sedat Evran | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,044 | 1,188 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Sedat Evran | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,044 | 3,132 | - | - | Restricted Stock Units | |
| Sedat Evran | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 346.37 per share. | 20 Oct 2024 | 335 | 853 (0%) | 0% | 346.4 | 116,034 | Bio-Rad A Common Stock |
| Arnold A. Pinkston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 308 | 308 | - | - | Restricted Stock Units | |
| Gregory K. Hinckley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 308 | 308 | - | - | Restricted Stock Units | |
| Roop K. Lakkaraju | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 6,143 | 6,143 | - | - | Restricted Stock Units | |
| Jeffrey L. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 308 | 308 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 13,822 | 13,822 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2024 | 3,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Andrew J. Last | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 329.94 per share. | 06 Sep 2024 | 3,000 | 7,559 (0%) | 0% | 329.9 | 989,815 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 299.24 per share. | 06 Sep 2024 | 3,000 | 10,559 (0%) | 0% | 299.2 | 897,720 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 3,456 | 3,456 | - | - | Restricted Stock Units | |
| Melinda Litherland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 308 | 308 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 369 | 369 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 2,304 | 2,304 | - | - | Restricted Stock Units | |
| Sedat Evran | EVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 3,456 | 3,456 | - | - | Restricted Stock Units | |
| James J. Barry | EVP, President, LSG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 4,224 | 4,224 | - | - | Restricted Stock Units | |
| Courtney Camp Enloe | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 3,072 | 3,072 | - | - | Restricted Stock Units | |
| Eva Anette Engelhardt | EVP, President, CDG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 4,608 | 4,608 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,266 | 1,266 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 3,005 | 435,925 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 1,607 | 434,318 (1%) | 0% | 337.3 | 542,073 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 2,081 | 436,399 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 801 | 435,598 (1%) | 0% | 337.3 | 270,193 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,266 | 436,864 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 545 | 436,319 (1%) | 0% | 337.3 | 183,839 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,805 | 438,124 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 965 | 437,159 (1%) | 0% | 337.3 | 325,514 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 2,320 | 439,479 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.31 per share. | 01 Sep 2024 | 1,241 | 438,238 (1%) | 0% | 334.3 | 414,879 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 3,005 | 9,015 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 2,081 | 4,164 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 2,320 | 0 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,805 | 0 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 635 | 6,375 (0%) | 0% | 337.3 | 214,198 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 903 | 0 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 633 | 633 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 867 | 1,735 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,252 | 3,756 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 458 | 7,559 (0%) | 0% | 337.3 | 154,493 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 903 | 8,017 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 321 | 7,114 (0%) | 0% | 337.3 | 108,280 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 633 | 7,435 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 440 | 6,802 (0%) | 0% | 337.3 | 148,421 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 867 | 7,242 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,252 | 7,010 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 520 | 1,042 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 405 | 406 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 434 | 0 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 557 | 0 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 751 | 7,324 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 268 | 7,056 (0%) | 0% | 337.3 | 90,402 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 520 | 7,576 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 218 | 7,358 (0%) | 0% | 337.3 | 73,536 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 405 | 7,763 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 145 | 7,618 (0%) | 0% | 337.3 | 48,911 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 434 | 8,052 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 155 | 7,897 (0%) | 0% | 337.3 | 52,285 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 557 | 8,454 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.31 per share. | 01 Sep 2024 | 283 | 8,171 (0%) | 0% | 334.3 | 94,610 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 751 | 2,254 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 31 | 1,268 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 74 | 1,250 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.31 per share. | 01 Sep 2024 | 35 | 1,215 (0%) | 0% | 337.3 | 11,806 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 42 | 1,257 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.30 per share. | 01 Sep 2024 | 20 | 1,237 (0%) | 0% | 337.3 | 6,746 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.33 per share. | 01 Sep 2024 | 15 | 1,253 (0%) | 0% | 337.3 | 5,060 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 44 | 1,297 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.33 per share. | 01 Sep 2024 | 21 | 1,276 (0%) | 0% | 337.3 | 7,084 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 56 | 1,332 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.30 per share. | 01 Sep 2024 | 27 | 1,305 (0%) | 0% | 334.3 | 9,026 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 74 | 224 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 42 | 84 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 31 | 31 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 44 | 0 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 56 | 0 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 129 | 18,161 (0%) | 0% | 337.3 | 43,514 | Bio-Rad A Common Stock |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 495 | 18,656 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Colleen Corey | EVP, Global Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.31 per share. | 01 Sep 2024 | 177 | 18,479 (0%) | 0% | 334.3 | 59,173 | Bio-Rad A Common Stock |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 500 | 1,503 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 347 | 694 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 253 | 254 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 361 | 0 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 495 | 0 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 361 | 18,290 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Colleen Corey | EVP, Global Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 91 | 17,929 (0%) | 0% | 337.3 | 30,696 | Bio-Rad A Common Stock |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 253 | 18,020 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Colleen Corey | EVP, Global Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 124 | 17,767 (0%) | 0% | 337.3 | 41,828 | Bio-Rad A Common Stock |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 347 | 17,891 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Colleen Corey | EVP, Global Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 179 | 17,544 (0%) | 0% | 337.3 | 60,380 | Bio-Rad A Common Stock |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 500 | 17,723 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 95 | 630 (0%) | 0% | 337.3 | 32,045 | Bio-Rad A Common Stock |
| James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 173 | 348 | - | - | Restricted Stock Units | |
| James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 250 | 752 | - | - | Restricted Stock Units | |
| James J. Barry | EVP, President, LSG | Sale of securities on an exchange or to another person at price $ 330.49 per share. | 01 Sep 2024 | 623 | 146 (0%) | 0% | 330.5 | 205,898 | Bio-Rad A Common Stock |
| James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.31 per share. | 01 Sep 2024 | 78 | 769 (0%) | 0% | 334.3 | 26,076 | Bio-Rad A Common Stock |
| James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 250 | 326 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 90 | 236 (0%) | 0% | 337.3 | 30,359 | Bio-Rad A Common Stock |
| James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 173 | 409 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 62 | 347 (0%) | 0% | 337.3 | 20,914 | Bio-Rad A Common Stock |
| James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 177 | 524 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| James J. Barry | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.31 per share. | 01 Sep 2024 | 64 | 460 (0%) | 0% | 337.3 | 21,588 | Bio-Rad A Common Stock |
| James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 265 | 725 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 217 | 847 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 217 | 0 | - | - | Restricted Stock Units | |
| James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 265 | 0 | - | - | Restricted Stock Units | |
| James J. Barry | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 177 | 178 | - | - | Restricted Stock Units | |
| Alice N. Schwartz | Ten Percent Owner, Director Emeritus | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 342 | 437,510 (8%) | 0% | 0 | Bio-Rad B Common Stock | |
| Alice N. Schwartz | Ten Percent Owner, Director Emeritus | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 3,190 | 1,781,356 (7%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 57 | 13,006 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 57 | 361,466 (7%) | 0% | 0 | Bio-Rad B Common Stock | |
| Schwartz D Steven | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 57 | 13,006 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Schwartz D Steven | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 57 | 25,234 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Allison Schwartz | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 57 | 3,996 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Eva Anette Engelhardt | EVP, President, CDG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 983 | 983 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 281.91 per share. | 13 Jun 2024 | 369 | 6,573 (0%) | 0% | 281.9 | 104,023 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2024 | 1,000 | 0 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.11 per share. | 29 Apr 2024 | 357 | 5,719 (0%) | 0% | 277.1 | 98,928 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2024 | 1,000 | 6,076 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Roop K. Lakkaraju | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 4,311 | 4,311 | - | - | Restricted Stock Units | |
| Courtney Camp Enloe | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 744 | 744 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 14,137 | 14,137 | - | - | Non-Qualified Stock Option (right to buy) | |
| Andrew J. Last | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 5,891 | 5,891 | - | - | Non-Qualified Stock Option (right to buy) | |
| Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 3,535 | 3,535 | - | - | Non-Qualified Stock Option (right to buy) | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 2,357 | 2,357 | - | - | Non-Qualified Stock Option (right to buy) | |
| Simon May | EVP, President, LSG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 3,535 | 3,535 | - | - | Non-Qualified Stock Option (right to buy) | |
| Colleen Corey | EVP, Global Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 2,357 | 2,357 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sedat Evran | EVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 3,535 | 3,535 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ernst S. Timothy | EVP, General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 330.55 per share. | 28 Feb 2024 | 2,500 | 3,397 (0%) | 0% | 330.6 | 826,375 | Bio-Rad A Common Stock |
| Ernst Timothy S. | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 326.15 per share. | 28 Feb 2024 | 2,500 | 5,897 (0%) | 0% | 326.2 | 815,375 | Bio-Rad A Common Stock |
| S. Timothy Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 2,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Crowley Michael | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 336.00 per share. | 27 Feb 2024 | 3,000 | 6,942 (0%) | 0% | 336 | 1,008,000 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 3,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Crowley Michael | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 215.98 per share. | 27 Feb 2024 | 3,000 | 9,942 (0%) | 0% | 216.0 | 647,940 | Bio-Rad A Common Stock |
| Dara Grantham Wright | EVP, President, CDG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2023 | 502 | 2,001 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Wright Dara Grantham | EVP, President, CDG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2023 | 502 | 503 | - | - | Restricted Stock Units | |
| Grantham Wright Dara | EVP, President, CDG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 306.12 per share. | 16 Dec 2023 | 174 | 1,827 (0%) | 0% | 306.1 | 53,265 | Bio-Rad A Common Stock |
| Dara Wright Grantham | EVP, President, CDG | Sale of securities on an exchange or to another person at price $ 299.16 per share. | 12 Dec 2023 | 1,200 | 1,499 (0%) | 0% | 299.2 | 358,992 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 49 | 12,949 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| N. Alice Schwartz | Ten Percent Owner, Director Emeritus | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 3,270 | 1,784,546 (7%) | 0% | 0 | Bio-Rad A Common Stock | |
| Schwartz Norman | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 49 | 361,409 (7%) | 0% | 0 | Bio-Rad B Common Stock | |
| D Steven Schwartz | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 49 | 12,949 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| N. Schwartz Alice | Ten Percent Owner, Director Emeritus | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 294 | 437,852 (8%) | 0% | 0 | Bio-Rad B Common Stock | |
| Allison Schwartz | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 49 | 3,939 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| D Steven Schwartz | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 49 | 25,177 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 305.10 per share. | 28 Nov 2023 | 642 | 6,942 (0%) | 0% | 305.1 | 195,874 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.00 per share. | 01 Nov 2023 | 12,024 | 361,360 (7%) | 0% | 273 | 3,282,552 | Bio-Rad B Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.32 per share. | 01 Nov 2023 | 15,000 | 373,384 (7%) | 0% | 159.3 | 2,389,800 | Bio-Rad B Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.00 per share. | 01 Nov 2023 | 12,274 | 358,384 (7%) | 0% | 273 | 3,350,802 | Bio-Rad B Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.56 per share. | 01 Nov 2023 | 16,000 | 370,658 (7%) | 0% | 139.6 | 2,232,960 | Bio-Rad B Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.00 per share. | 01 Nov 2023 | 25,642 | 354,658 (6%) | 0% | 273 | 7,000,266 | Bio-Rad B Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.80 per share. | 01 Nov 2023 | 35,000 | 380,300 (7%) | 0% | 119.8 | 4,193,000 | Bio-Rad B Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2023 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2023 | 35,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2023 | 15,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sedat Evran | EVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2023 | 4,176 | 4,176 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 12,020 | 12,020 | - | - | Restricted Stock Units | |
| Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 240 | 1,966 (0%) | 0% | 394.6 | 94,704 | Bio-Rad A Common Stock |
| Ilan Daskal | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 4,007 | 4,007 | - | - | Restricted Stock Units | |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 694 | 2,082 | - | - | Restricted Stock Units | |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 456 | 912 | - | - | Restricted Stock Units | |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 542 | 542 | - | - | Restricted Stock Units | |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 694 | 2,206 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 269 | 2,486 (0%) | 0% | 394.6 | 106,147 | Bio-Rad A Common Stock |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 542 | 2,755 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 209 | 2,213 (0%) | 0% | 394.6 | 82,471 | Bio-Rad A Common Stock |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 456 | 2,422 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 5,008 | 5,008 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 903 | 5,487 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 279 | 4,584 (0%) | 0% | 394.6 | 110,093 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 633 | 4,863 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 430 | 4,230 (0%) | 0% | 394.6 | 169,678 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 867 | 4,660 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 903 | 903 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 633 | 1,266 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 867 | 2,602 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 448 | 5,039 (0%) | 0% | 394.6 | 176,781 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 180 | 6,380 (0%) | 0% | 394.6 | 71,028 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 0 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 557 | 557 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 434 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 811 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 1,562 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 3,005 | 3,005 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 298 | 7,584 (0%) | 0% | 394.6 | 117,591 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 7,882 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 202 | 7,282 (0%) | 0% | 394.6 | 79,709 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 557 | 7,484 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 150 | 6,927 (0%) | 0% | 394.6 | 59,190 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 7,077 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 141 | 6,644 (0%) | 0% | 394.6 | 55,639 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 6,785 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 6,560 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 500 | 0 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 500 | 3,631 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 231 | 3,131 (0%) | 0% | 394.6 | 91,153 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 464 | 3,362 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 179 | 2,898 (0%) | 0% | 394.6 | 70,633 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 361 | 3,077 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 126 | 2,716 (0%) | 0% | 394.6 | 49,720 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 253 | 2,842 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 173 | 2,589 (0%) | 0% | 394.6 | 68,266 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 347 | 2,762 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 2,003 | 2,003 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 347 | 1,041 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 248 | 3,383 (0%) | 0% | 394.6 | 97,861 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 253 | 507 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 361 | 361 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 464 | 464 | - | - | Restricted Stock Units | |
| Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 2,831 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 434 | - | - | Restricted Stock Units | |
| Dara Grantham Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 141 | 2,398 (0%) | 0% | 394.6 | 55,639 | Bio-Rad A Common Stock |
| Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 2,539 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Dara Grantham Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 180 | 2,134 (0%) | 0% | 394.6 | 71,028 | Bio-Rad A Common Stock |
| Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 2,314 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Dara Grantham Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 150 | 2,681 (0%) | 0% | 394.6 | 59,190 | Bio-Rad A Common Stock |
| Dara Grantham Wright | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 3,005 | 3,005 | - | - | Restricted Stock Units | |
| Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 1,562 | - | - | Restricted Stock Units | |
| Dara Grantham Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 811 | - | - | Restricted Stock Units | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 173 | 196 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 60 | 136 (0%) | 0% | 394.6 | 23,676 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 169 | 305 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.59 per share. | 01 Sep 2023 | 59 | 246 (0%) | 0% | 394.6 | 23,281 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 241 | 487 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 84 | 403 (0%) | 0% | 394.6 | 33,146 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 173 | 521 | - | - | Restricted Stock Units | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 169 | 338 | - | - | Restricted Stock Units | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 241 | 241 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 526 | 2,981 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Simon May | EVP, President, LSG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 3,005 | 3,005 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 295 | 3,104 (0%) | 0% | 394.6 | 116,407 | Bio-Rad A Common Stock |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 3,399 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 182 | 2,799 (0%) | 0% | 394.6 | 71,817 | Bio-Rad A Common Stock |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 409 | 410 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 371 | 744 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 526 | 526 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 0 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 1,562 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 2,126 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 180 | 1,946 (0%) | 0% | 394.6 | 71,028 | Bio-Rad A Common Stock |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 371 | 2,317 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 129 | 2,188 (0%) | 0% | 394.6 | 50,903 | Bio-Rad A Common Stock |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 409 | 2,597 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 142 | 2,455 (0%) | 0% | 394.6 | 56,033 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 41 | 1,068 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.59 per share. | 01 Sep 2023 | 17 | 1,051 (0%) | 0% | 394.6 | 6,708 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 30 | 1,081 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.58 per share. | 01 Sep 2023 | 12 | 1,069 (0%) | 0% | 394.6 | 4,735 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 44 | 1,113 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.61 per share. | 01 Sep 2023 | 18 | 1,095 (0%) | 0% | 394.6 | 7,103 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 56 | 1,151 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.61 per share. | 01 Sep 2023 | 23 | 1,128 (0%) | 0% | 394.6 | 9,076 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 82 | 1,210 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.59 per share. | 01 Sep 2023 | 34 | 1,176 (0%) | 0% | 394.6 | 13,416 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 298 | 298 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 41 | 126 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 30 | 62 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 44 | 44 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 56 | 56 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 82 | 0 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 0 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 495 | 495 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 361 | 361 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 329 | 659 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 1,562 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 275 | 11,880 (0%) | 0% | 394.6 | 108,515 | Bio-Rad A Common Stock |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 12,155 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Diane Dahowski | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 172 | 11,555 (0%) | 0% | 394.6 | 67,871 | Bio-Rad A Common Stock |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 495 | 11,727 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Diane Dahowski | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 125 | 11,232 (0%) | 0% | 394.6 | 49,325 | Bio-Rad A Common Stock |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 361 | 11,357 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Diane Dahowski | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 114 | 10,996 (0%) | 0% | 394.6 | 44,984 | Bio-Rad A Common Stock |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 329 | 11,110 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Diane Dahowski | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 180 | 10,781 (0%) | 0% | 394.6 | 71,028 | Bio-Rad A Common Stock |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 10,961 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 347 | 16,227 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Colleen Corey | EVP, Global Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 120 | 16,107 (0%) | 0% | 394.6 | 47,352 | Bio-Rad A Common Stock |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 0 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 495 | 495 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 361 | 361 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 253 | 507 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 347 | 1,041 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 2,003 | 2,003 | - | - | Restricted Stock Units | |
| Colleen Corey | EVP, Global Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 208 | 17,223 (0%) | 0% | 394.6 | 82,077 | Bio-Rad A Common Stock |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 17,431 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Colleen Corey | EVP, Global Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 172 | 16,831 (0%) | 0% | 394.6 | 67,871 | Bio-Rad A Common Stock |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 495 | 17,003 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Colleen Corey | EVP, Global Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 125 | 16,508 (0%) | 0% | 394.6 | 49,325 | Bio-Rad A Common Stock |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 361 | 16,633 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Colleen Corey | EVP, Global Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 88 | 16,272 (0%) | 0% | 394.6 | 34,725 | Bio-Rad A Common Stock |
| Colleen Corey | EVP, Global Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 253 | 16,360 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 215.98 per share. | 30 Aug 2023 | 2,350 | 4,765 (0%) | 0% | 216.0 | 507,553 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2023 | 2,350 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 396.44 per share. | 30 Aug 2023 | 377 | 2,415 (0%) | 0% | 396.4 | 149,458 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 395.76 per share. | 30 Aug 2023 | 1,582 | 2,792 (0%) | 0% | 395.8 | 626,092 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 394.16 per share. | 30 Aug 2023 | 391 | 4,374 (0%) | 0% | 394.2 | 154,117 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 1,266 | 2,532 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,081 | 6,245 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 25,389 | 345,300 (6%) | 0% | 381.8 | 9,693,012 | Bio-Rad B Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.50 per share. | 25 Aug 2023 | 39,000 | 370,689 (7%) | 0% | 117.5 | 4,582,500 | Bio-Rad B Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 1,290 | 432,920 (1%) | 0% | 381.8 | 492,496 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,600 | 434,210 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 1,151 | 431,610 (1%) | 0% | 381.8 | 439,429 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,320 | 432,761 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 895 | 430,441 (1%) | 0% | 381.8 | 341,693 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 1,805 | 431,336 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 628 | 429,531 (1%) | 0% | 381.8 | 239,758 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 1,266 | 430,159 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 1,032 | 428,893 (1%) | 0% | 381.8 | 393,997 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,081 | 429,925 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 39,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,600 | 0 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,320 | 2,320 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 1,805 | 1,805 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 384.69 per share. | 23 Aug 2023 | 300 | 2,415 (0%) | 0% | 384.7 | 115,407 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 379.39 per share. | 15 Jun 2023 | 500 | 6,040 (0%) | 0% | 379.4 | 189,695 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 376.12 per share. | 06 Jun 2023 | 17 | 181 (0%) | 0% | 376.1 | 6,394 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 368.28 per share. | 06 Jun 2023 | 181 | 0 (0%) | 0% | 368.3 | 66,659 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 1,000 | 4,112 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 1,000 | 1,000 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 450.79 per share. | 29 Apr 2023 | 346 | 3,766 (0%) | 0% | 450.8 | 155,973 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 277 | 294 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 277 | 554 | - | - | Restricted Stock Units | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 450.79 per share. | 29 Apr 2023 | 96 | 198 (0%) | 0% | 450.8 | 43,276 | Bio-Rad A Common Stock |
| Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 466.24 per share. | 08 Apr 2023 | 243 | 1,493 (0%) | 0% | 466.2 | 113,296 | Bio-Rad A Common Stock |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2023 | 700 | 700 | - | - | Restricted Stock Units | |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2023 | 700 | 1,736 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.32 per share. | 08 Mar 2023 | 850 | 4,267 (0%) | 0% | 159.3 | 135,422 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 150 | 2,350 | - | - | Non-Qualified Stock Option (right to buy) | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 850 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 486.89 per share. | 08 Mar 2023 | 746 | 2,671 (0%) | 0% | 486.9 | 363,220 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Sale of securities on an exchange or to another person at price $ 486.08 per share. | 08 Mar 2023 | 1,000 | 3,417 (0%) | 0% | 486.1 | 486,080 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 215.98 per share. | 08 Mar 2023 | 150 | 4,417 (0%) | 0% | 216.0 | 32,397 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 644 | 644 | - | - | Restricted Stock Units | |
| Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 502 | 1,987 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 502 | 1,005 | - | - | Restricted Stock Units | |
| Dara Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 407.98 per share. | 16 Dec 2022 | 226 | 1,761 (0%) | 0% | 408.0 | 92,203 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 421.70 per share. | 10 Nov 2022 | 267 | 112 (0%) | 0% | 421.7 | 112,594 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 422.28 per share. | 10 Nov 2022 | 112 | 0 (0%) | 0% | 422.3 | 47,295 | Bio-Rad A Common Stock |
| Alice N. Schwartz | Ten Percent Owner, Director Emeritus | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 252 | 438,146 (8%) | 0% | 0 | Bio-Rad B Common Stock | |
| Alice N. Schwartz | Ten Percent Owner, Director Emeritus | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 2,639 | 1,787,816 (7%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 42 | 12,900 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 42 | 331,689 (6%) | 0% | 0 | Bio-Rad B Common Stock | |
| Schwartz D Steven | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 42 | 12,900 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Schwartz D Steven | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 42 | 25,128 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Allison Schwartz | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 42 | 3,890 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,600 | 0 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,600 | 2,600 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,319 | 4,640 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 1,805 | 3,610 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 1,575 | 427,844 (1%) | 0% | 478.3 | 753,354 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,600 | 429,419 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 1,575 | 426,819 (1%) | 0% | 478.3 | 753,354 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,600 | 428,394 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 1,405 | 425,794 (1%) | 0% | 478.3 | 672,040 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,319 | 427,199 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 1,094 | 424,880 (1%) | 0% | 478.3 | 523,282 | Bio-Rad A Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 1,805 | 425,974 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 541 | 1,084 | - | - | Restricted Stock Units | |
| Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 269 | 953 (0%) | 0% | 478.3 | 128,668 | Bio-Rad A Common Stock |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 541 | 1,222 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 448 | 3,083 (0%) | 0% | 478.3 | 214,287 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 902 | 1,806 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 902 | 3,531 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 298 | 6,540 (0%) | 0% | 478.3 | 142,539 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 6,838 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 298 | 6,238 (0%) | 0% | 478.3 | 142,539 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 6,536 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 241 | 5,936 (0%) | 0% | 478.3 | 115,275 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 150 | 5,620 (0%) | 0% | 478.3 | 71,748 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 557 | 6,177 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 433 | 5,770 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 0 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 600 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 557 | 1,114 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 433 | 867 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 361 | 722 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 500 | 0 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 500 | 500 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 464 | 928 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 248 | 3,405 (0%) | 0% | 478.3 | 118,623 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 500 | 3,653 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 248 | 3,153 (0%) | 0% | 478.3 | 118,623 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 500 | 3,401 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 161 | 2,901 (0%) | 0% | 478.3 | 77,010 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 464 | 3,062 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 125 | 2,598 (0%) | 0% | 478.3 | 59,790 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 361 | 2,723 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Dara Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 150 | 1,459 (0%) | 0% | 478.3 | 71,748 | Bio-Rad A Common Stock |
| Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 433 | 1,609 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 433 | 867 | - | - | Restricted Stock Units | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 241 | 482 | - | - | Restricted Stock Units | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 84 | 365 (0%) | 0% | 478.3 | 40,179 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 241 | 449 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 1,848 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 285 | 1,248 (0%) | 0% | 478.3 | 136,321 | Bio-Rad A Common Stock |
| Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 182 | 933 (0%) | 0% | 478.3 | 87,054 | Bio-Rad A Common Stock |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 0 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 600 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 526 | 1,052 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 409 | 819 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 298 | 1,550 (0%) | 0% | 478.3 | 142,539 | Bio-Rad A Common Stock |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 1,533 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 409 | 731 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 142 | 589 (0%) | 0% | 478.3 | 67,921 | Bio-Rad A Common Stock |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 526 | 1,115 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 82 | 82 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 80 | 0 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 34 | 980 (0%) | 0% | 478.3 | 16,263 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 82 | 1,014 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 43 | 917 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.30 per share. | 02 Sep 2022 | 23 | 932 (0%) | 0% | 478.3 | 11,001 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 56 | 955 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.33 per share. | 02 Sep 2022 | 18 | 899 (0%) | 0% | 478.3 | 8,610 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 80 | 1,060 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.33 per share. | 02 Sep 2022 | 33 | 1,027 (0%) | 0% | 478.3 | 15,785 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 43 | 88 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 56 | 112 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 0 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 361 | 9,598 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Diane Dahowski | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 125 | 9,473 (0%) | 0% | 478.3 | 59,790 | Bio-Rad A Common Stock |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 495 | 9,968 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Diane Dahowski | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 188 | 9,780 (0%) | 0% | 478.3 | 89,924 | Bio-Rad A Common Stock |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 10,380 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Diane Dahowski | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 298 | 10,082 (0%) | 0% | 478.3 | 142,539 | Bio-Rad A Common Stock |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 10,682 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Diane Dahowski | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 298 | 10,384 (0%) | 0% | 478.3 | 142,539 | Bio-Rad A Common Stock |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 361 | 722 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 495 | 990 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 600 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 1,266 | 424,936 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 8,326 | 8,326 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 1,266 | 3,798 | - | - | Restricted Stock Units | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 767 | 424,169 (1%) | 0% | 486.3 | 372,954 | Bio-Rad A Common Stock |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 455 | 1,368 | - | - | Restricted Stock Units | |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 455 | 907 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 226 | 681 (0%) | 0% | 486.3 | 109,893 | Bio-Rad A Common Stock |
| Ilan Daskal | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,776 | 2,776 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 3,469 | 3,469 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 633 | 2,943 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 314 | 2,629 (0%) | 0% | 486.3 | 152,683 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 633 | 1,899 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 405 | 1,216 | - | - | Restricted Stock Units | |
| Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 405 | 5,478 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 141 | 5,337 (0%) | 0% | 486.2 | 68,561 | Bio-Rad A Common Stock |
| Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,082 | 2,082 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 88 | 2,362 (0%) | 0% | 486.3 | 42,790 | Bio-Rad A Common Stock |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 253 | 760 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 1,388 | 1,388 | - | - | Restricted Stock Units | |
| Timothy S. Ernst | EVP, General Counsel & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 253 | 2,450 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Dara Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 141 | 1,176 (0%) | 0% | 486.2 | 68,561 | Bio-Rad A Common Stock |
| Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 405 | 1,317 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Dara Wright | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,082 | 2,082 | - | - | Restricted Stock Units | |
| Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 405 | 1,216 | - | - | Restricted Stock Units | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 694 | 694 | - | - | Restricted Stock Units | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 169 | 267 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 169 | 507 | - | - | Restricted Stock Units | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 59 | 208 (0%) | 0% | 486.3 | 28,689 | Bio-Rad A Common Stock |
| Simon May | EVP, President, LSG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,082 | 2,082 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 371 | 1,115 | - | - | Restricted Stock Units | |
| Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 129 | 322 (0%) | 0% | 486.2 | 62,726 | Bio-Rad A Common Stock |
| Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 371 | 451 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 30 | 92 | - | - | Restricted Stock Units | |
| Allison Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 30 | 886 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Allison Schwartz | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 12 | 874 (0%) | 0% | 486.3 | 5,835 | Bio-Rad A Common Stock |
| Allison Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 167 | 167 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,082 | 2,082 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 329 | 988 | - | - | Restricted Stock Units | |
| Diane Dahowski | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 114 | 9,237 (0%) | 0% | 486.3 | 55,433 | Bio-Rad A Common Stock |
| Diane Dahowski | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 329 | 9,351 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2022 | 39,250 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 107.32 per share. | 26 Aug 2022 | 39,250 | 355,396 (6%) | 0% | 107.3 | 4,212,310 | Bio-Rad B Common Stock |
| Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 495.28 per share. | 26 Aug 2022 | 23,749 | 331,647 (6%) | 0% | 495.3 | 11,762,405 | Bio-Rad B Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 537.00 per share. | 05 Aug 2022 | 518 | 98 (0%) | 0% | 537 | 278,166 | Bio-Rad A Common Stock |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 1,000 | 2,764 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Andrew J. Last | EVP, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 1,000 | 2,000 | - | - | Restricted Stock Units | |
| Andrew J. Last | EVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 512.06 per share. | 29 Apr 2022 | 471 | 2,293 (0%) | 0% | 512.1 | 241,180 | Bio-Rad A Common Stock |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 277 | 697 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 277 | 831 | - | - | Restricted Stock Units | |
| Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 512.06 per share. | 29 Apr 2022 | 96 | 601 (0%) | 0% | 512.1 | 49,158 | Bio-Rad A Common Stock |
| Ilan Daskal | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 597.16 per share. | 08 Apr 2022 | 257 | 452 (0%) | 0% | 597.2 | 153,470 | Bio-Rad A Common Stock |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2022 | 700 | 709 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Ilan Daskal | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2022 | 700 | 1,400 | - | - | Restricted Stock Units | |
| Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2021 | 502 | 1,113 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Dara Wright | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 734.34 per share. | 16 Dec 2021 | 221 | 892 (0%) | 0% | 734.3 | 162,289 | Bio-Rad A Common Stock |
| Dara Wright | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2021 | 502 | 1,507 | - | - | Restricted Stock Units | |
| Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 524.30 per share. | 11 Nov 2021 | 433 | 6,139 (0%) | 0% | 524.3 | 227,022 | Bio-Rad A Common Stock |
| Annette Tumolo | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 333.34 per share. | 11 Nov 2021 | 500 | 5,706 (0%) | 0% | 333.3 | 166,670 | Bio-Rad A Common Stock |